These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27159446)

  • 1. Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
    Buerth C; Mausberg AK; Heininger MK; Hartung HP; Kieseier BC; Ernst JF
    PLoS One; 2016; 11(5):e0155082. PubMed ID: 27159446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG
    Giralt M; Molinero A; Hidalgo J
    Methods Mol Biol; 2018; 1791():227-232. PubMed ID: 30006713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice.
    Bittner S; Afzali AM; Wiendl H; Meuth SG
    J Vis Exp; 2014 Apr; (86):. PubMed ID: 24797125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
    Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N
    J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in mice.
    Tselios T; Aggelidakis M; Tapeinou A; Tseveleki V; Kanistras I; Gatos D; Matsoukas J
    Molecules; 2014 Nov; 19(11):17968-84. PubMed ID: 25375337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG
    Triantafyllakou I; Clemente N; Khetavat RK; Dianzani U; Tselios T
    Mol Pharm; 2022 Nov; 19(11):3795-3805. PubMed ID: 36098508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble MOG35-55/I-A(b) dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells.
    Gong Y; Wang Z; Liang Z; Duan H; Ouyang L; Yu Q; Xu Z; Shen G; Weng X; Wu X
    PLoS One; 2012; 7(10):e47435. PubMed ID: 23077616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35-55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6.
    Seo JE; Hasan M; Han JS; Kim NK; Lee JE; Lee KM; Park JH; Kim HJ; Son J; Lee J; Kwon OS
    Neurochem Res; 2016 Apr; 41(4):666-76. PubMed ID: 26464215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
    Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
    Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells.
    Nosratabadi R; Rastin M; Sankian M; Haghmorad D; Tabasi N; Zamani S; Aghaee A; Salehipour Z; Mahmoudi M
    J Immunotoxicol; 2016 May; 13(3):364-74. PubMed ID: 26634391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
    J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic MOG
    Lourbopoulos A; Deraos G; Matsoukas MT; Touloumi O; Giannakopoulou A; Kalbacher H; Grigoriadis N; Apostolopoulos V; Matsoukas J
    Bioorg Med Chem; 2017 Aug; 25(15):4163-4174. PubMed ID: 28642030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.
    Kasarello K; Kwiatkowska-Patzer B; Lipkowski AW; Bardowski JK; Szczepankowska AK
    Med Sci Monit; 2015 May; 21():1587-97. PubMed ID: 26026273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.
    Duncker PC; Stoolman JS; Huber AK; Segal BM
    J Immunol; 2018 Feb; 200(3):966-973. PubMed ID: 29288202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide.
    Weir CR; Nicolson K; Bäckström BT
    Immunol Cell Biol; 2002 Feb; 80(1):14-20. PubMed ID: 11869358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
    Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
    Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    McLaughlin PJ; McHugh DP; Magister MJ; Zagon IS
    BMC Immunol; 2015 Apr; 16():24. PubMed ID: 25906771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
    Boullerne AI; Polak PE; Braun D; Sharp A; Pelligrino D; Feinstein DL
    J Neurochem; 2014 May; 129(4):696-703. PubMed ID: 24471474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
    Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; Renò F; Dianzani U
    Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection.
    Fraga-Silva TF; Mimura LA; Marchetti CM; Chiuso-Minicucci F; França TG; Zorzella-Pezavento SF; Venturini J; Arruda MS; Sartori A
    J Immunol Res; 2015; 2015():635052. PubMed ID: 25969836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.